Acnatac

Acnatac combines clindamycin and tretinoin for topical acne treatment. This dual-action formula targets acne-causing bacteria and promotes skin cell turnover. Ideal for managing moderate to severe acne.

Acnatac is a topical medication used primarily for acne treatment. It combines clindamycin, an antibiotic, with tretinoin, a retinoid, to address acne from multiple angles. Clindamycin helps reduce acne-causing bacteria, while tretinoin promotes skin cell turnover, unclogging pores and preventing new breakouts. This combination is often recommended for individuals with moderate to severe acne who have not responded to other treatments.

When applied to the skin, Acnatac may cause initial dryness, redness, or peeling. These effects are usually mild and temporary as the skin adjusts to the treatment. Some users may experience a temporary increase in acne before seeing improvement. It is important to follow the usage instructions provided by a healthcare professional to minimize potential irritation.

Acnatac should be used as directed and applied only to clean, dry skin. Avoid contact with the eyes, mouth, and other mucous membranes. It is advisable to use sunscreen during treatment, as tretinoin can increase the skin's sensitivity to sunlight. Individuals with a history of allergic reactions to clindamycin or tretinoin should avoid using this medication.

Acnatac may interact with other topical medications, particularly those containing sulfur, resorcinol, or salicylic acid. It is important to inform your healthcare provider about all medications you are currently using. Additionally, avoid using harsh soaps or exfoliants while using Acnatac, as they can increase the risk of skin irritation.